An investigational monovalent human papillomavirus (HPV) 16 virus-like particle vaccine
has been shown to prevent persistent infection and cervical disease related to HPV 16 and …

Objectives Increasing evidence suggests that extended human papillomavirus (HPV)
genotyping (beyond 16/18) is effective for risk stratification in women with normal cytology …

Cervical cancer prevention is based on primary prevention with vaccines against Human
Papillomavirus (HPV) and secondary prevention by screening with High‐Risk‐HPV (Hr …

Background Some studies demonstrated that female genital mycoplasmas play important
roles in human papillomavirus (HPV) infection, abnormal cervical cytopathology, and …

This study investigated the distribution of HPV types in Korean women and evaluated the
carcinogenic risk of individual HPV types and the potential effects of HPV vaccines. A total of …

Cervical cancer is estimated to cause 341,831 deaths each year, with 9 of 10 deaths
occurring in developing countries. Over the past decade, there has been a significant …

Background The aim of the study was to investigate the risk of human papillomavirus (HPV)
genotyping particularly vaccine genotypes and multiple infections for cervical precancer and …

Atherosclerosis manifests by the thickening of artery walls and their narrowed channels
through the accumulation of plaque. It is one of the most important indicators of …

Cervical cancer is one of the most common causes of cancer-related deaths in women
worldwide. Despite advances in current therapies, women with advanced or recurrent …

Background: The Human Papillomavirus (HPV) is a DNA tumor virus that causes epithelial
proliferation. There are more than 100 HPV subtypes, of which 13 subtypes are regarded as …